SCHEMBL13623251

SCHEMBL13623251

c1ccc2c(c1)CCc1cc(-c3ccc(-c4ccc5c(c4)CCc4ccccc4N5c4ccc5ccccc5c4)cc3)ccc1N2c1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
HSD17B3 P37058 2/20 0.40
HTR3A P46098 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR5A P47898 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623259 0.89 ALDH1A1 (0.41) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13623257 0.89 ALDH1A1 (0.47) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL12414459 0.87 ESR1 (0.42) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13623253 0.83 HSD17B3 (0.48) HSP90AA1ALDH1A1CYP1A2HPGDHSD17B3
SCHEMBL13009006 0.82 HPGD (0.45) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13428117 0.82 ALDH1A1 (0.38) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL12175900 0.82 ALDH1A1 (0.38) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13428157 0.81 ALDH1A1 (0.37) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13008419 0.80 HSD17B3 (0.38) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13009032 0.80 HSD17B3 (0.38) HSP90AA1ALDH1A1LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R HSP90AA1 4725/4885ALDH1A1 379/4885LMNA 2827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.